DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam · Delayed Price · Currency is VND 100,400
+100 (0.10%)
At close: Apr 10, 2026
DHG Pharmaceutical JSC Revenue
In the year 2025, DHG Pharmaceutical JSC had annual revenue of 5.27T VND with 7.82% growth. DHG Pharmaceutical JSC had revenue of 1.74T in the quarter ending December 31, 2025, with 19.46% growth.
Revenue
5.27T
Revenue Growth
+7.82%
P/S Ratio
2.49
Revenue / Employee
1.87B
Employees
2,819
Market Cap
13.13T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.27T | 382.10B | 7.82% |
| Dec 31, 2024 | 4.88T | -130.53B | -2.60% |
| Dec 31, 2023 | 5.02T | 339.38B | 7.26% |
| Dec 31, 2022 | 4.68T | 672.85B | 16.81% |
| Dec 31, 2021 | 4.00T | 247.55B | 6.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Traphaco JSC | 2.66T |
| Imexpharm | 2.44T |
| Ha Tay Pharmaceutical JSC | 2.40T |
| Domesco Medical Import - Export Joint-Stock | 2.07T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| OPC Pharmaceutical JSC | 1.12T |
| Vidipha Central Pharmaceutical JSC | 985.64B |